Tested positive for covid after being fully vaccinated.; Tested positive for covid after being fully vaccinated.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 63-year-old male patient received BNT162b2 (BNT162B2), in Apr2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 63 years for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 10Mar2021 as dose 1, single (Lot number: 003A21A), on 07Apr2021 as dose 2, single (Lot number: 013A21A) and on 08Dec2021 as dose 3 (booster), single (Lot number: 058A21A) for covid-19 immunisation. The patient's relevant medical history included: "cholesterol" (unspecified if ongoing). Concomitant medication(s) included: ATORVASTATIN oral taken for blood cholesterol abnormal. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 13Jul2022, outcome "unknown" and all described as "Tested positive for covid after being fully vaccinated.". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: The second he tested positive; (13Jul2022) Positive, notes: When he was first diagnosed with covid 13Jul2022 he did not have issues with taste and smell; (Jul2022) Positive, notes: Tested positive for covid in Jul 2022 after being vaccinated; (27Jul2022) Positive, notes: He tested again on Wednesday of last week 27Jul2022 and was still showing positive; (31Jul2022) Negative, notes: He tested negative for covid for the first time yesterday 31Jul2022. He lost his sense of taste and smell around the 20th or 21st of Jul2022. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Caller is a consumer report side effect with Paxlovid. He recently had covid and he received a prescription for Paxlovid. During the time he took Paxlovid, he had mild symptoms described as a funky taste in his mouth and he did have rebound covid where he lost his sense of smell and taste. He is like when he had covid before. He is full vaccinated. He confirmed contact details agent provided. The second he tested positive he called the doctor and was given a prescription. Clarifies he had symptoms of covid on 12Jul2022, he started taking Paxlovid 13Jul2022 around 4pm in the afternoon.  Funky taste started the first day, he described it as a soapy grapefruit, but more in the back of his mouth, it permeated through his sinuses in back of his mouth. He could not get rid of it with water or food. It was not all the time, it was intermittent. On rebound covid he did lose his sense of smell and taste. Clarifies he never stopped testing positive after the initial covid diagnosis prior to starting Paxlovid. He had not been testing daily. He tested again on Wednesday of last week 27Jul2022 and was still showing positive. He tested negative for covid for the first time yesterday 31Jul2022. He lost his sense of taste and smell around the 20th or 21st of Jul 2022.  He sense of smell and taste came back this weekend, it was partial and then came back fully this weekend.  When he had a sinus infection and colds before, there were times where he could not taste or smell, it was similar to that.  When the back of his sinuses finally cleared out, that is when his taste and smell recovered. When he was first diagnosed with covid 13Jul2022 he did not have issues with taste and smell. He did stop taking his statin per his doctors order, did not take statin on 13Jul2022 and the days after that, so that there was no drug interaction. Clarifies started taking statin again on 20Jul2022. Atorvastatin 20mg does not have it handy to provide lot, ndc or expiration. Product information states that there would be an interaction as his doctor told him. States he has brain fog when attempting to remember dates for when he started back on his statin. Tested positive for covid after being fully vaccinated.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.